Helping you value, protect and capitalise on your greatest assets

Brand, content & intellectual property

If you have a brand or intellectual property issue, we provide clear and workable solutions to secure and safeguard your most important intangible assets.

Knowledge and expertise

Whatever stage at the business process you're at, you can rely on us for sound strategic advice, robust representation and absolute focus on delivering your commercial objectives.

  • Intellectual Property
  • Patents
  • Brand and reputation
  • Content and media
Intellectual Property

Because we understand that leveraging intellectual capital to create a business edge is a key driver for business growth, we'll work with you to develop, exploit and protect your intellectual property rights.

Whether you're creating, acquiring or commercialising your intellectual property rights, or need support with specific copyright, trade mark, design and trade secret issues, we offer proactive solutions and dispute resolution assistance.


MinterEllison’s patents team has a wealth of experience across all aspects of domestic and international patent advisory and dispute matters – ranging from strategy to licensing, freedom to operate, opposition, infringement and revocation proceedings. We are particularly experienced in working as part of global litigation teams coordinating strategy across jurisdictions. Our clients span the biotechnology, pharmaceutical, medical device, chemical, electronics, mining, engineering, consumer and agricultural industries.

Our multidisciplinary team includes dual-qualified lawyers with scientific qualifications and most of our patent attorneys are also qualified lawyers. Our science experience stretches from chemistry, life sciences and biotechnology, to engineering and IT.

Brand and reputation

We offer proactive strategies to help protect your most important assets – your business brand and reputation.

Our specialist advisers can support your business from advertising and brand promotion strategies and legal risk assessment of marketing offers, product performance claims and sponsorships, to strategic re-branding, ambush marketing and marketing and brand-related dispute resolution and large-scale litigation.

Content and media

Our specialist advisers work at the leading edge of evolving forms of content and communications, including print, internet and broadcast media.

We offer creative solutions to support the full spectrum of your media-related needs, from defamation, pre-publication advice, contempt, suppression orders, and legislative restrictions on publication and advertising codes, to ecommerce content issues, internet manuscript and programme content.

Visit our Intellect blog home to sign up to our newsletter.


  • Fairfax Media - successful Supreme Court application to revoke a Commonwealth Government suppression order relating to foreign bribery charges against former senior executives of a Reserve Bank of Australia subsidiary
  • Guardian News and Media - regulatory compliance issues of its commercial and editorial activities in Australia and compliance with its multi-jurisdictional initiatives
  • Calidad - an alleged breach of statutory duty, involving sections 145 and 148 of the Trade Marks Act, which have never previously been considered in Australia
  • Helloworld Limited - rebranding of one of Australia's largest travel organisations, the Jetset Travel Group
  • Foxtel - a number of matters including its action against a number of ISPs under a new, untested section of the Copyright Act, under which it is sought to block certain pirate websites
  • AFL - the joint AFL/Australian Sports Anti-Doping Authority investigation into the Essendon Football Club's 2012 supplements program, and acting for the AFL in relation to related Federal and Supreme Court litigation, the AFL Anti-Doping Tribunal proceedings, and the World Anti-Doping Authority's appeal to the international Court of Arbitration for Sport (CAS)
  • Pandora Media, Inc. - a multi-jurisdictional licensing dispute in relation to music sound recording use in Australia and New Zealand
  • Various organisations on the management of their global trademark portfolios
  • Bristol-Myers Squibb and Ono Pharmaceutical - patent revocation proceedings brought by Merck Sharpe & Dohme, regarding a patent for the use of certain antibodies in the treatment of cancer.
  • Calidad v Seiko Epson - acted for Calidad in the first repair/remanufacture case in Australia, concerning the sale of used remanufactured printer cartridges.
  • Watson Pharma & Ascent Pharma (Actavis) (Federal Court and High Court of Australia) – succeeded in invalidating AstraZeneca’s patents relating to rosuvastatin (Crestor); upheld on appeal; appeal by AZ to High Court dismissed.

You might also be interested in: